Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns
- PMID: 22247624
- PMCID: PMC3255995
- DOI: 10.2147/JPR.S27310
Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns
Abstract
Background: The purpose of this study was to identify differences in perceptions of care regarding postherpetic neuralgia, including communication patterns between patients and physicians and levels of satisfaction with therapies and care.
Methods: A survey was developed for physicians (neurologists, internists, and family physicians) and patients with postherpetic neuralgia in order to determine their perspectives on its management.
Results: A total of 142 eligible patient respondents were included in the study, and responses were compared with those of 150 primary care physicians and 76 neurologist respondents. Few patients and physicians indicated satisfaction with the currently available treatments for postherpetic neuralgia. While nearly all physicians responded that they discuss the cause of postherpetic neuralgia with a patient, one in four patients indicated that their physician did not discuss the cause. Similarly, one in four patients were not aware of the duration of postherpetic neuralgia, the treatment side effects, or what to expect from treatment. Patients may be less likely to discuss treatment side effects and quality of life issues than physicians perceive.
Conclusion: Physicians and patients have similar perceptions regarding treatment options for postherpetic neuralgia; however, certain gaps in communication were evident, which may be attributable to physician knowledge and communication skills with patients. Strategies to improve issues of expected outcomes and side effects of treatment may be useful to physicians.
Keywords: case vignette; pain; patient communication; postherpetic neuralgia.
Similar articles
-
[Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].Rev Epidemiol Sante Publique. 2010 Dec;58(6):393-401. doi: 10.1016/j.respe.2010.06.166. Epub 2010 Nov 20. Rev Epidemiol Sante Publique. 2010. PMID: 21094001 French.
-
Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.J Multidiscip Healthc. 2016 Sep 21;9:447-454. doi: 10.2147/JMDH.S106340. eCollection 2016. J Multidiscip Healthc. 2016. PMID: 27703368 Free PMC article. Review.
-
Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.Pain Physician. 2019 May;22(3):209-228. Pain Physician. 2019. PMID: 31151330
-
Is peptic ulcer disease a risk factor of postherpetic neuralgia in patients with herpes zoster?Med Hypotheses. 2013 Nov;81(5):834-8. doi: 10.1016/j.mehy.2013.09.007. Epub 2013 Sep 17. Med Hypotheses. 2013. PMID: 24074834
-
Peptic ulcer as a risk factor for postherpetic neuralgia in adult patients with herpes zoster.J Med Virol. 2015 Feb;87(2):222-9. doi: 10.1002/jmv.24051. Epub 2014 Aug 22. J Med Virol. 2015. PMID: 25156435
Cited by
-
Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.J Manag Care Spec Pharm. 2019 Dec;25(12):1387-1396. doi: 10.18553/jmcp.2019.19093. Epub 2019 Oct 7. J Manag Care Spec Pharm. 2019. PMID: 31589557 Free PMC article.
-
Bee venom treatment for refractory postherpetic neuralgia: a case report.J Altern Complement Med. 2014 Mar;20(3):212-4. doi: 10.1089/acm.2013.0130. Epub 2013 Oct 5. J Altern Complement Med. 2014. PMID: 24093469 Free PMC article.
-
Practical considerations in the pharmacological treatment of postherpetic neuralgia for the primary care provider.J Pain Res. 2014 Mar 10;7:125-32. doi: 10.2147/JPR.S57242. eCollection 2014. J Pain Res. 2014. PMID: 24648752 Free PMC article. Review.
-
Low Trend for VZV-Associated Disease Patients to Visit Neurologists.J Multidiscip Healthc. 2023 May 16;16:1379-1392. doi: 10.2147/JMDH.S412398. eCollection 2023. J Multidiscip Healthc. 2023. PMID: 37215749 Free PMC article.
-
Validity of Plasma Neuropeptide Y in Combination with Clinical Factors in Predicting Neuralgia Following Herpes Zoster.Int J Gen Med. 2024 Oct 18;17:4805-4814. doi: 10.2147/IJGM.S480411. eCollection 2024. Int J Gen Med. 2024. PMID: 39440102 Free PMC article.
References
-
- Johnson RW, Wasner G, Saddier P, Baron R. Herpes zoster and postherpetic neuralgia: Optimizing management in the elderly patient. Drugs Aging. 2008;25(12):991–1006. - PubMed
-
- Harpaz R, Ortega-Sanchez IR, Seward JF Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) Prevention of herpes zoster: Recommendations of the advisory committee on immunization practices (ACIP) MMWR Recomm Rep. 2008;57(RR-5):1–30. - PubMed
-
- Dubinsky RM, Kabbani H, El-Chami Z, Boutwell C, Ali H. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Treatment of postherpetic neuralgia: An evidence-based report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2004;63(6):959–965. - PubMed
-
- Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: Results from a population-based survey. J Pain. 2005;6(6):356–363. - PubMed
LinkOut - more resources
Full Text Sources